03
03
Location:
Homepage
>
>
>
Gong Huaqiang, chairman and general manager of the company, attended the kick-off ceremony of China's biological antibody industrialization base construction project (Phase I)

Gong Huaqiang, chairman and general manager of the company, attended the kick-off ceremony of China's biological antibody industrialization base construction project (Phase I)

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2020-09-21
  • Views:0

(Summary description)On September 10, 2020, the China Biological Antibody Industrialization Base Construction Project (Phase I) supervised by Shanghai Project Management Co., Ltd. (SPM) held a groundbreaking ceremony. Gong Huaqiang, chairman and general manager of the company, was invited to attend as a representative of the supervisory unit.

Gong Huaqiang, chairman and general manager of the company, attended the kick-off ceremony of China's biological antibody industrialization base construction project (Phase I)

(Summary description)On September 10, 2020, the China Biological Antibody Industrialization Base Construction Project (Phase I) supervised by Shanghai Project Management Co., Ltd. (SPM) held a groundbreaking ceremony. Gong Huaqiang, chairman and general manager of the company, was invited to attend as a representative of the supervisory unit.

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2020-09-21
  • Views:0
Information

September 10, 2020, China Bioantibody, supervised by Shanghai Project Management Co., Ltd. (SPM) The launching ceremony of the industrialization base construction project (Phase I) was held. Gong Huaqiang, chairman and general manager of the company, was invited to attend as a representative of the supervisory unit.

The leaders and guests attending the ceremony included Wu Yonglin, Deputy Secretary of the Party Committee and President of China Biotech, Li Xiangrong, Vice President, Secretary of the Disciplinary Committee and President Zhou Song, Legal Counsel, Wang Yu, Deputy Secretary of the Shanghai Science and Technology Work Party Committee, Gu Qi, Deputy District Mayor of Fengxian District, Shanghai, Shi Lan, Director of the Drug Supervision Division of the Shanghai Municipal Drug Administration, and Deputy Director of the Biomedical Division of the Shanghai Municipal Economic and Information Commission Liu Houjia, Wei Xin, fourth-level researcher of the Drug Administration Department of Shanghai Municipal Health Commission, Li Yi, Party Secretary and Chairman of Shanghai Fengxian District Oriental Beauty Valley Enterprise Group Co., Ltd., Li Xiuling, Party Secretary and General Manager of Shanghai Institute of Biological Products, etc.

Secretary of the Party Committee and General Manager of Shanghai Institute of Biological Products Li Xiuling, Deputy Chief of Fengxian District, Shanghai Gu Yu, China Biotechnology Vice President Li Xiangrong delivered speeches successively. Finally, in the warm applause of the audience, Wu Yonglin, Deputy Secretary of the Party Committee and President of China Biotech, announced that the "China Biological Antibody Industrialization Base Construction Project (Phase I)" had officially started. The foundation of the project was laid.

Since this year, SPM has continued to increase attention and resource investment in medical and health projects, and steadily promote talent introduction and training , Laying a solid foundation for the successful bidding of the project. Next, SPM will resolutely fulfill the contract agreement, earnestly assume the supervision service responsibilities, continue to strengthen the supervision and management of safety and quality, escort the high-quality advancement of the project, create high-quality projects, and win customer recognition with professional and high-quality services.

Project Introduction: The China Biological Antibody Industrialization Base Construction Project (Phase I) is located in Fengxian District, Shanghai, with a construction area of 6 More than 10,000 square meters, including 8 buildings (structures), will build 4 antibody production lines and become China's biological antibody industry base. After the completion of the project, it will have the ability to produce 9 large-scale antibody drugs at the same time, and the sales volume is expected to reach more than 5 billion yuan.

 

Scan the QR code to read on your phone

SPM

Shanghai Project Management Co., Ltd.

Registration number/unified social credit code : 91310230631413987X    © 2020 Copyright  Shanghai Project Management Co., Ltd.  沪ICP备05015636号  

Designed By:www.300.cn